newsfilter
← Latest News
GlobeNewswire·

MapLight Therapeutics to Participate in Upcoming Investor Conferences

  • MapLight Therapeutics (NASDAQ: MPLT) management will present at the 2026 RBCCM Global Healthcare Conference in New York on May 19, 2026.
  • The company will also present at the 2026 Jefferies Global Healthcare Conference in New York on June 3, 2026.
  • Both events will include presentations & hosted one-on-one meetings.
  • Live webcasts & archived recordings will be available on the company's Investor Relations website at https://ir.maplightrx.com/news-events/events-presentations.
  • MapLight Therapeutics is a clinical-stage biopharmaceutical company focused on developing circuit-specific pharmacotherapies for central nervous system disorders.
  • The company was founded by leaders in psychiatry & neuroscience to target neural circuits causally linked to disease.